Therefore, timely normalisation of the mitochondrial Zn2+ level via downregulation or inactivation of the mitochondrial ZIP7 expression could be beneficial for patients with acute myocardial infarction and other cardiovascular diseases. This evidence concerns the gene SLC39A7 and myocardial infarction.